Healthline
November 17, 2025
Share on PinterestSleeping in total darkness may help lower your risk of cardiovascular disease. d3sign/Getty Images A recent study reports that exposure to light during sleep […]
November 16, 2025
Share on PinterestMost Americans would try a plant-based diet to prevent diabetes, a recent poll shows. Image credit: Maria Korneeva/Getty Images New research says people are […]
November 14, 2025
Share on PinterestUltra-processed foods may contribute to the risk of early-onset colorectal cancer in women, study warns. A new study reports that there is an association […]
November 14, 2025
Share on PinterestThe TrumpRx prescription drug savings program is expected to be available by early 2026. Eli Lilly and Novo Nordisk have agreed to sell their […]
Medscape
July 8, 2025
Obesity often brings about, or exacerbates, depression and anxiety. Yet some of the most effective drugs for managing depression are also known to cause weight gain. […]
July 8, 2025
Despite dramatic treatment advances in recent years, the dermatology community has lacked a unified definition for what remission means in plaque psoriasis. Now, a multistage Delphi […]
July 8, 2025
Could a simple advisory or alert in the electronic medical record (EMR) be the key to more frequent diagnosis and effective treatment of high blood pressure […]
July 8, 2025
In young children, the long-term effects of SARS-CoV-2 infection may differ significantly from those in older children or adults. A recent study in JAMA Pediatrics systematically […]
FDA
November 19, 2025
On November 19, 2025, the Food and Drug Administration granted traditional approval to daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech Inc.) with bortezomib, cyclophosphamide, and dexamethasone […]
November 19, 2025
Resources The innovative regulatory approaches resulting from the 21st Century Cures Act are modernizing new drug development. The use of clinical trials with Master Protocol design […]
November 19, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
November 19, 2025
On November 19, 2025, the Food and Drug Administration approved selumetinib (KOSELUGO, AstraZeneca Pharmaceuticals LP) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable […]
